FOMAT is a Site Management Organization that only manages high-producing sites. Our smallest site has 147 beds while our largest site has 846 beds. Together our sites have a network of over 10 million patients. This enables us to surpass our enrollment goals. We are more than just an SMO. We spearhead ethics committee and MOH approval in our countries and have internal quality controls that enable us to keep our data from being compromised. We have various international sites located in the United States and Latin America. FOMAT, an American company, possesses the professional expertise, competence, and commitment to assist pharmaceutical companies and/or other contract research organizations in the early stages of launching a clinical trial through FDA approval. FOMAT is an SMO that specializes in directing the project development, while simultaneously excelling in producing quality data in a timely, cost-effective, and efficient manner. We are committed to integrating our experience and proficiency in clinical trial management which will continue to contribute to the betterment of healthcare around the world.